Novo Nordisk: mission, interessenter og etik

Novo Nordisk is a global healthcare company that strive on diabetes care. They have more than 95 years of innovation and leadership on diabetic knowledge which they carry on expanding. They have grown to become the world’s largest supplier of insulin.

Novo Nordisk are dedicated on creating value for their patients by changing the diabetic world. They intend to change how it is treated, how it is viewed around the world and how the future of the disease evolves. They plan to be the best in their business by being the world’s leading diabetes care company. Novo Nordisk are the world’s largest supplier of insulin and they have 27% of market shares in the Diabetes region. Their key contribution is to discover, develop and manufacture better medicines and to make them even more accessible throughout the world. Novo Nordisk want to address the risk factors which are highly found in cities as cities influence how people live, travel and eat; all of them being factors to bad health. It is shown that 2/3 of people with diabetes have a city lifestyle. In today’s world every 3 in 4 people with diabetes live in low- and middle-income countries where millions of people lack the means to afford it therefore Novo Nordisk endlessly work on the improvement of accessibility, affordability and availability of the medicines needed. They aim to develop a cure through research and investigations which they hope will prevent diabetes.